Cargando…

A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer

This study examined the relationship of achievable mean dose and percent volumetric overlap of salivary gland with the planning target volume (PTV) in volumetric-modulated arc therapy (VMAT) plan in radiotherapy for a patient with head-and-neck cancer. The aim was to develop a model to predict the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honglai, Cao, Yijian, Antone, Jeffrey, Riegel, Adam C., Ghaly, Maged, Potters, Louis, Jamshidi, Abolghassem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764180/
https://www.ncbi.nlm.nih.gov/pubmed/31576068
http://dx.doi.org/10.4103/jmp.JMP_19_19
_version_ 1783454324850950144
author Zhang, Honglai
Cao, Yijian
Antone, Jeffrey
Riegel, Adam C.
Ghaly, Maged
Potters, Louis
Jamshidi, Abolghassem
author_facet Zhang, Honglai
Cao, Yijian
Antone, Jeffrey
Riegel, Adam C.
Ghaly, Maged
Potters, Louis
Jamshidi, Abolghassem
author_sort Zhang, Honglai
collection PubMed
description This study examined the relationship of achievable mean dose and percent volumetric overlap of salivary gland with the planning target volume (PTV) in volumetric-modulated arc therapy (VMAT) plan in radiotherapy for a patient with head-and-neck cancer. The aim was to develop a model to predict the viability of planning objectives for both PTV coverage and organs-at-risk (OAR) sparing based on overlap volumes between PTVs and OARs, before the planning process. Forty patients with head-and-neck cancer were selected for this retrospective plan analysis. The patients were treated using 6 MV photons with 2-arc VMAT plan in prescriptions with simultaneous integrated boost in dose of 70 Gy, 63 Gy, and 58.1 Gy to primary tumor sites, high-risk nodal regions, and low-risk nodal regions, respectively, over 35 fractions. A VMAT plan was generated using Varian Eclipse (V13.6), in optimization with biological-based generalized equivalent uniform dose (gEUD) objective for OARs and targets. Target dose coverage (D(95), D(max), conformity index) and salivary gland dose (D(mean) and D(max)) were evaluated in those plans. With a range of volume overlaps between salivary glands and PTVs and dose constraints applied, results showed that dose D(95) for each PTV was adequate to satisfy D(95) >95% of the prescription. Mean dose to parotid <26 Gy could be achieved with <20% volumetric overlap with PTV(58) (parotid-PTV(58)). On an average, the D(mean) was seen at 15.6 Gy, 21.1 Gy, and 24.2 Gy for the parotid-PTV(58) volume at <5%, <10%, and <20%, respectively. For submandibular glands (SMGs), an average D(mean) of 27.6 Gy was achieved in patients having <10% overlap with PTV(58), and 36.1 Gy when <20% overlap. Mean doses on parotid and SMG were linearly correlated with overlap volume (regression R(2) = 0.95 and 0.98, respectively), which were statistically significant (P < 0.0001). This linear relationship suggests that the assessment of the structural overlap might provide prospective for achievable planning objectives in the head-and-neck plan.
format Online
Article
Text
id pubmed-6764180
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67641802019-10-01 A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer Zhang, Honglai Cao, Yijian Antone, Jeffrey Riegel, Adam C. Ghaly, Maged Potters, Louis Jamshidi, Abolghassem J Med Phys Technical Note This study examined the relationship of achievable mean dose and percent volumetric overlap of salivary gland with the planning target volume (PTV) in volumetric-modulated arc therapy (VMAT) plan in radiotherapy for a patient with head-and-neck cancer. The aim was to develop a model to predict the viability of planning objectives for both PTV coverage and organs-at-risk (OAR) sparing based on overlap volumes between PTVs and OARs, before the planning process. Forty patients with head-and-neck cancer were selected for this retrospective plan analysis. The patients were treated using 6 MV photons with 2-arc VMAT plan in prescriptions with simultaneous integrated boost in dose of 70 Gy, 63 Gy, and 58.1 Gy to primary tumor sites, high-risk nodal regions, and low-risk nodal regions, respectively, over 35 fractions. A VMAT plan was generated using Varian Eclipse (V13.6), in optimization with biological-based generalized equivalent uniform dose (gEUD) objective for OARs and targets. Target dose coverage (D(95), D(max), conformity index) and salivary gland dose (D(mean) and D(max)) were evaluated in those plans. With a range of volume overlaps between salivary glands and PTVs and dose constraints applied, results showed that dose D(95) for each PTV was adequate to satisfy D(95) >95% of the prescription. Mean dose to parotid <26 Gy could be achieved with <20% volumetric overlap with PTV(58) (parotid-PTV(58)). On an average, the D(mean) was seen at 15.6 Gy, 21.1 Gy, and 24.2 Gy for the parotid-PTV(58) volume at <5%, <10%, and <20%, respectively. For submandibular glands (SMGs), an average D(mean) of 27.6 Gy was achieved in patients having <10% overlap with PTV(58), and 36.1 Gy when <20% overlap. Mean doses on parotid and SMG were linearly correlated with overlap volume (regression R(2) = 0.95 and 0.98, respectively), which were statistically significant (P < 0.0001). This linear relationship suggests that the assessment of the structural overlap might provide prospective for achievable planning objectives in the head-and-neck plan. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6764180/ /pubmed/31576068 http://dx.doi.org/10.4103/jmp.JMP_19_19 Text en Copyright: © 2019 Journal of Medical Physics http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Technical Note
Zhang, Honglai
Cao, Yijian
Antone, Jeffrey
Riegel, Adam C.
Ghaly, Maged
Potters, Louis
Jamshidi, Abolghassem
A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title_full A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title_fullStr A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title_full_unstemmed A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title_short A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer
title_sort model-based method for assessment of salivary gland and planning target volume dosimetry in volumetric-modulated arc therapy planning on head-and-neck cancer
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764180/
https://www.ncbi.nlm.nih.gov/pubmed/31576068
http://dx.doi.org/10.4103/jmp.JMP_19_19
work_keys_str_mv AT zhanghonglai amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT caoyijian amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT antonejeffrey amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT riegeladamc amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT ghalymaged amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT potterslouis amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT jamshidiabolghassem amodelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT zhanghonglai modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT caoyijian modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT antonejeffrey modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT riegeladamc modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT ghalymaged modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT potterslouis modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer
AT jamshidiabolghassem modelbasedmethodforassessmentofsalivaryglandandplanningtargetvolumedosimetryinvolumetricmodulatedarctherapyplanningonheadandneckcancer